William M. Evans, JD
Corporate Counsel, Patents, Bristol-Myers Squibb
William M. Evans has over a decade of experience working with innovator companies in the pharmaceutical industry. As a Corporate Counsel of Patents at Bristol-Meyers Squibb, he manages an extensive world-wide patent portfolio for products in all stages of development. Additionally, William performs due diligence and provides guidance on in/out licensing of assets and partner collaborations. William’s patent strategies have protected several cutting edge therapies, including Spinraza and Idhifa. William also advises on issues related to pharmaceutical life-cycle management, freedom to operate, and licensing transactions. William completed a joint BS in Chemistry/BA in History, as well as a MS in Chemistry at UC San Diego, and earned his law degree from the University of San Diego.